carvedilol has been researched along with Angina, Stable in 4 studies
Angina, Stable: Persistent and reproducible chest discomfort usually precipitated by a physical exertion that dissipates upon cessation of such an activity. The symptoms are manifestations of MYOCARDIAL ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol is a non-selective β-blocker with α₁-adrenergic receptor antagonism properties." | 2.48 | A critical review of the use of carvedilol in ischemic heart disease. ( Abrencillo, R; Chen-Scarabelli, C; Di Rezze, J; Faggian, G; Gardin, T; Gidwani, UK; Murad, Y; Qureshi, W; Saravolatz, L; Scarabelli, TM; Shieh, WS, 2012) |
| "90 patients with chronic form of ischemic heart disease that have been involved in present study along with nitrates, antiplatelet agents and statins received bisoprolol (Group I), carvedilol (Group II) and ivabradine (Group III)." | 1.42 | [The comparative effectiveness of beta-blockers and inhibitors of if-iodium using in patients with stable angina pectoris]. ( Ilashchuk, T; Okipniak, I; Shirokova, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shirokova, S | 1 |
| Ilashchuk, T | 1 |
| Okipniak, I | 1 |
| Oh, PC | 1 |
| Kang, WC | 1 |
| Moon, J | 1 |
| Park, YM | 1 |
| Kim, S | 1 |
| Kim, MG | 1 |
| Lee, K | 1 |
| Ahn, T | 1 |
| Shin, EK | 1 |
| Chen-Scarabelli, C | 1 |
| Saravolatz, L | 2 |
| Murad, Y | 1 |
| Shieh, WS | 1 |
| Qureshi, W | 1 |
| Di Rezze, J | 1 |
| Abrencillo, R | 1 |
| Gardin, T | 1 |
| Gidwani, UK | 1 |
| Faggian, G | 1 |
| Scarabelli, TM | 1 |
| Riccioni, G | 1 |
| Prencipe, G | 1 |
| Benvenuto, A | 1 |
| Masciocco, L | 1 |
| Ventra, S | 1 |
| Rizzo, U | 1 |
| Russi, C | 1 |
| Speziale, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris[NCT02547597] | Phase 4 | 99 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carvedilol and Angina, Stable
| Article | Year |
|---|---|
A critical review of the use of carvedilol in ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina, Stable; Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythm | 2012 |
2 trials available for carvedilol and Angina, Stable
| Article | Year |
|---|---|
Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Angina, Stable; Atenolol; Carbazoles; Cardiotonic Agen | 2016 |
Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Atenolol; Benzazepines; Bisoprolol; Carbazoles; C | 2013 |
1 other study available for carvedilol and Angina, Stable
| Article | Year |
|---|---|
[The comparative effectiveness of beta-blockers and inhibitors of if-iodium using in patients with stable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Bisoprolol; Carbazoles; Carvedilol; Elect | 2015 |